ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mark B. Ratcliffe
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guccione, J. M.
Right arrow Articles by Ratcliffe, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guccione, J. M.
Right arrow Articles by Ratcliffe, M. B.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2003;76:1171-1180
© 2003 The Society of Thoracic Surgeons


Original article: cardiovascular

Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study

Julius M. Guccione, PhDa,b,d*, Ali Salahieh, BSa, Scott M. Moonly, BSb, Jeroen Kortsmit, BSe, Arthur W. Wallace, MD, PhDc, Mark B. Ratcliffe, MDa,b

a Department of Surgery, San Francisco, CA, USA
b Department of Bioengineering, San Francisco, CA, USA
c Department of Anesthesia, Division of Cardiothoracic Surgery, School of Medicine of the University of California, San Francisco, California, USA
d San Francisco Veterans Affairs Medical Center, San Francisco, California, USA
e Department of Biophysics, Maastricht University, Maastricht, the the Netherlands

Accepted for publication April 18, 2003.

* Address reprint requests to Dr Guccione, Division of Surgical Services (112D), San Francisco Veterans Affairs Medical Center, 4150 Clement St, San Francisco, CA 94121, USA
e-mail: julius.guccione{at}med.va.gov


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
BACKGROUND: The Myocor Myosplint is a transcavitary tensioning device designed to change left ventricular (LV) shape and reduce wall stress. Regional wall stress cannot be measured in the intact heart and LV function after surgical remodeling is often confounded by inotropic agents and mitral repair. We used a realistic mathematical (finite element) model of the dilated human LV to test the hypothesis that Myosplint decreased regional ventricular fiber stress and improved LV function.

METHODS: A finite element model was used to simulate the effects of Myosplint on the LV stroke volume/end-diastolic pressure (Starling) relationship and regional distributions of stress in the local muscle fiber direction (fiber stress) for a wide range of diastolic and end-systolic material properties. The nonlinear stress-strain relationship for the diastolic myocardium was anisotropic with respect to the local muscle fiber direction. An elastance model for active fiber stress was incorporated in an axisymmetric geometric model of the globally dilated LV wall.

RESULTS: Both diastolic compliance and end-systolic elastance shifted to the left on the pressure-volume diagram. LV end-diastolic volume and end-systolic volumes were reduced by 7.6% and 8.6%, respectively. Mean end-diastolic and end-systolic fiber stress was decreased by 24% and 16%, respectively. Although the effect of Myosplint on the Starling relationship was not significant, there were trends toward an improvement in this relationship at low diastolic stiffness, C, high peak intracellular calcium concentration, Ca0, and high arterial elastance, EA. Of note, the effect of C was twice that of Ca0 and EA. Diastolic function would, therefore, be expected to be the prime determinant of success with Myosplint.

CONCLUSIONS: Myosplint reduces fiber stress without a decrement in the Starling relationship. Myosplint should be much more effective than partial ventriculectomy as a surgical therapy for patients with dilated cardiomyopathy and end-stage congestive heart failure.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

Drs Ratcliffe and Salahieh disclose that they have a financial relationship with Myocor, Inc (Maple Grove, MN).

 

Reduction of left ventricular (LV) wall stress is a cornerstone in the treatment of heart failure. First, the time integral of systolic stress is proportional to myocardial oxygen consumption in the normal [1], and stunned LV [2], and in the failing LV with hypertrophy [3]. Second, increased ventricular wall stress causes structural changes (remodeling) in the LV [4, 5] that adversely affect ventricular performance and patient survival. Mechanisms include stress mediated myocyte hypertrophy, increased myocyte apoptosis [6], altered matrix metalloproteinase (MMP), collagen turnover [7], and myocyte Ca2+ handling [8]. Conversely, LV unloading with chronic assist device therapy has been reported to decrease beta receptor density, improve Ca2+ cycling [9], and downregulate MMPs [10].

The Myocor Myosplint (Myocor Inc., Maple Grove, MN) is a transcavitary tensioning device designed to change ventricular shape and reduce wall stress [11]. Typically, three Myosplints, each consisting of two epicardial pads connected by a tension member, are placed along the long axis of the LV. This draws the opposing anterior and posterior walls of the LV together and creates a bilobular cross-section with decreased chamber radius [11]. Using LaPlace’s law to calculate wall stress, application of the Myosplint device in dogs with pacing tachycardia induced heart failure [11] caused an acute reduction in end-diastolic and end-systolic wall stress of 40% and 18%, respectively.

Ventricular wall stress, which cannot be measured directly, has traditionally been estimated with LaPlace’s law. However, the use of LaPlace’s law in this case is not appropriate. First, the calculation of transmural variations in stress through the LV wall is impossible using an analysis based on a global force balance rather than on knowledge of material properties because LaPlace’s law can only predict the average stress across the wall thickness. Second, application of LaPlace’s law to the complex bilobar LV shape that occurs with Myosplint devices requires knowledge of the tension in these devices, which has never been measured. Finally, Myosplint devices probably are associated with regional stress variations and stress concentrations at the Myosplint anchor sites, for which LaPlace’s law cannot account.

Surgical procedures (such as partial ventriculectomy, aneurysm repair, and Myosplint) can achieve substantial LV volume and stress reduction [12, 13] but the cost of surgical volume reduction may include a reduction in LV function. Specifically, operations that alter ventricular size, shape, or regional stiffness effect both diastolic compliance and end-systolic elastance and those changes have a net effect on ventricular function [15]. For example, although partial ventriculectomy improves end-systolic elastance, diastolic compliance is reduced more and the net effect is a decrement in the Starling relationship [14, 15]. Previous studies using Myosplint devices in dogs with pacing tachycardia induced heart failure [11], and in sheep with anteroapical myocardial infarction [16] did not demonstrate a significant change in cardiac output and suggest a balanced effect of Myosplint on end-systolic elastance and diastolic compliance.

The goal of the present study was to use a realistic finite element model of a globally dilated left ventricle to simulate the effect of Myosplint on regional fiber stress and the Starling relationship. To determine the extent to which myocardial material properties influence the effectiveness of Myosplint, we used nine different combinations of diastolic and systolic material properties. We tested the hypothesis that application of the Myosplint devices decreases regional wall stress and improves LV function.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Overview of finite element model
A finite element model of a globally dilated LV was developed (Fig 1A). Finite element meshes were created and loaded with a range of physiologic intraventricular pressures with the use of the three-dimensional method of Costa and associates [17] for large elastic deformations of ventricular myocardium, together with the mathematical descriptions for diastolic and systolic myocardial material properties (stress-strain relations) of Guccione and associates [18]. Finite element modeling and analysis were performed on a Unix-based workstation (Octane2; SGI, Mountain View, CA).



View larger version (40K):
[in this window]
[in a new window]
 
Fig 1. The globally dilated left ventricular model (A) in unpressurized state and the same finite element model (B) after the diameters at the points of application of three Myosplints have been reduced so that they are 75% of those at end-diastole (25% reduction). The red rendered surface is the endocardium; blue lines outline the finite elements; arrows indicate the points of Myosplint attachment.

 
Structure
Initial unloaded configuration
The unloaded dilated LV shape is a thick-walled axisymmetric truncated ellipsoid with cavity and wall volumes of 213 and 333 mL, respectively, and a diameter-to-length ratio of 0.732 (Fig 1A). As in our previous work [19], diastolic dimensions of the unloaded dilated LV were chosen empirically, and when the diastolic model was loaded with an intracavitary LV pressure of 20 mm Hg, LV dimensions approximate dimensions from patients with dilated cardiomyopathy [20]. The muscle fiber orientation throughout the LV was assumed to vary (linearly) in the transmural direction from 60-degrees counterclockwise from the circumferential direction at the endocardium to 60-degrees clockwise from circumferential at the epicardium, based on experimental measurements by Streeter and associates [21] in canine hearts owing to the absence of these data from patients with dilated cardiomyopathy. The sarcomere length throughout the LV was assumed to be 1.845 µm, in accordance with the suggestion of Kresh and Wechsler [22] that a dilated, volume-overloaded heart is devoid of residual stress and the stress-free sarcomere length measured in rats by Rodriguez and associates [23]. Our current understanding of human LV residual stress clearly is lacking. In a previous study using the same finite element methodology [19], however, we found that residual stress produced by ventricular volume reduction surgery has little effect on ventricular function and mechanics.

Finite element mesh and boundary conditions
The finite element model was meshed with three-dimensional solid (continuum) elements (eight nodes, trilinear nodal displacement interpolation in prolate spheroidal coordinates, constant hydrostatic pressure within each element). Longitudinal displacement of all nodes at the apex and base and circumferential displacement of the epicardial node at the base were constrained. These constrained degrees of freedom prevent a hole from opening up at the apex and provide longitudinal and circumferential frames of reference for displacements, respectively. Because stress and strain are independent of rigid body motion, our solutions would be the same if we instead allowed the LV base to move up and down (during diastole and systole, respectively) and used the epicardial node at the apex as a frame of reference for longitudinal and circumferential displacement. It should be noted that the apical and basal nodes were allowed to move in the radial or transmural direction. Converged solutions were obtained when the mesh was refined into 4 elements transmurally, 8 elements longitudinally, and 12 elements circumferentially (for a total of 384). The effect of element number on end-systolic and end-diastolic pressure-volume relationships differed by only 3% when the number of elements was increased from 180 to 384 elements. Finally, these results did not depend on the "path" the model took in the pressure-volume plane (e.g., it did not matter whether end-systole was simulated directly or after diastolic filling). This finite element mesh facilitated comparison between our finite element model analyses of ventricular volume reduction surgery and Myosplint. Having a more realistic geometrical shape would have necessitated an increase in the number of elements beyond our present computational capabilities.

Material properties
Diastolic material properties
Both diastolic and systolic material properties of the LV wall were assumed to be homogeneous and anisotropic. Diastolic material properties were described by the strain energy potential, W, developed by Guccione and associates [18] to describe myocardium as a nonlinear material that is anisotropic (transversely isotropic) with respect to the local muscle fiber direction:

(1)
where E11 is fiber strain, E22 is cross-fiber in-plane strain, E33 is radial strain, E23 is shear in the transverse plane, and E12 and E13 are shear strain in the fiber-cross fiber and fiber-radial coordinate planes, respectively. Guccione and associates [24] found that the material constants C = 0.876 kPa, bf = 18.48, bt = 3.58, and bfs = 1.627 allowed a cylindrical model of the LV to match epicardial strains measured in an intact canine heart preparation during passive LV filling. Diastolic LV dysfunction was modeled by increasing the variable C to 1.1 kPa ("reduced compliance") and then to 1.4 kPa ("failing") (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. End-Systolic and Diastolic Material Property Combinations Used in Finite Element Simulations

 
Systolic material properties
The end-systolic material properties of the LV wall were obtained by defining the stress components referred to fiber coordinates as the sum of the end-diastolic three-dimensional stress components derived from the strain energy potential (by partial differentiation with respect to the corresponding strain component) and an active fiber-directed component, which was a function of time, peak intracellular calcium concentration, Ca0, and sarcomere length [18]. To simulate systolic LV dysfunction, we reduced Ca0 from 2.66 µmol/L to 2.3 µmol/L ("depressed") and then to 2.00 µmol/L ("failing") (Table 1).

Myosplint simulations
The effects of a typical (25%) reduction in end-diastolic diameter at the points of application of three Myosplints devices were simulated with the use of the globally dilated heart model. Typically about 3 cm separate the Myosplints devices from the LV base and each other. To determine the epicardial diameters at these three longitudinal positions for each type of diastolic material property (normal, reduced compliance, and failing) the model was loaded passively up to an LV pressure of 20 mm Hg (2.67 kPa). Then, the radial and longitudinal displacement of the epicardial node to which each Myosplint device was attached (six nodes) were specified so that the epicardial diameter was reduced by 25% (Fig 1B). Longitudinal displacements of the nodes at the apex and base were constrained, and pressures on the endocardial and epicardial surfaces were set to zero. Residual stresses in the new unloaded configurations were taken into account by treating the initial unloaded configurations before splinting as the stress-free reference configuration.

Calculation of diastolic and End-Systolic Pressure-Volume relationships
Diastolic and end-systolic solutions were obtained at ranges of end-diastolic (i.e., 0 to 20 mm Hg) and end-systolic (i.e., 0 to 120 mm Hg) chamber pressures. The end-systolic pressure (PES) and end-systolic volume (VES), and end-diastolic pressure (PED) and end-diastolic volume (VED) relationships were fit to the following quadratic equations using least squares regression analysis [25]. The end-systolic pressure-volume relationship is:

(2)
where ß0,EES, ß1,EES, and ß2,EES are the stiffness variables of the LV end-systolic elastance. The quadratic term, ß2,EESVES, was added to the normally linear end-systolic relationship to better model significant nonlinearity in the end-systolic pressure-volume relationship (Fig 2B).



View larger version (15K):
[in this window]
[in a new window]
 
Fig 2. (A) Effect of a 25% reduction in end-diastolic diameter (Myosplint) on end-systolic elastance ({square} = preoperative; {blacksquare} = Myosplint) and diastolic compliance ({circ} = preoperative; = Myosplint). (B) Nonlinearity of end-systolic elastance before and after Myosplint. In A and B, values are average (nine end-systolic models and three diastolic models). *p < 0.05 by multivariate regression. (LV = left ventricle.)

 
The end-diastolic pressure-volume relationship is:

(3)
where ß0,DC, ß1,DC, and ß2,DC are the stiffness variables of the LV diastolic compliance.

Calculation of stroke Volume/PED (Starling) relationship
For each combination of end-systolic and diastolic material properties, before and after simulated Myosplint procedure, a stroke volume/PED (Starling) relationship was calculated by constructing a series of pressure-volume loops that were bounded by the end-systolic and diastolic pressure-volume relationships of the simulation. VED initially corresponded to a PED of 20 mm Hg and was incrementally decreased for subsequent loops. In order to calculate the end-systolic pressure-volume point on each loop, the arterial elastance, EA, was either calculated by fixing LV pressure at 100 mm Hg to correspond to our previous methodology [19] or fixed at 2.5 ± 0.5 to correspond to EA values measured in patients with dilated cardiomyopathy [26]. However, because the end-systolic pressure-volume relationship was significantly nonlinear (Fig 2B) the following equation was used to find the intersection between the arterial elastance line and the end-systolic pressure-volume relationship:

(4)
where EA is the slope and VED is the volume intercept of the arterial elastance. VES was then calculated using the quadratic equation.

The Starling relationship is:

(5)
where ß0,Starling, ß1,Starling, and ß2,Starling are the stiffness variables of the Starling relationship.

Calculation of diastolic and systolic fiber stress
For each combination of diastolic and systolic material properties, stress in the local muscle fiber direction was computed (using the finite element equations 8 and 10 of Costa and associates [17]) throughout the LV wall at end-diastole and end-systole of the initial pressure-volume loop (PED = 20 mm Hg; PES = 100 mm Hg). Transmural fiber stress distributions "near" the points of application of the three Myosplints were obtained from the centers of the 96 elements (where the hydrostatic pressure component of stress is most accurate) that come in contact with the splints (Fig 4A). The 96 elements with interelement boundaries that are perpendicular to (or rotated 90 degrees in the short-axis plane away from) the Myosplints were used to compute transmural fiber stress distributions "far" from their points of application (Fig 4A). To obtain "overall" end-diastolic and end-systolic fiber stresses we calculated the mean values from the centers of all 384 finite elements. Each fiber stress value was "weighted" in these calculations by the relative volume of its corresponding element. It should be noted that the mean fiber stress values do not correspond to those calculated by a global force balance (the "Law of Laplace"), which does not take into account the transmural variation in muscle fiber orientation (nor myocardial material properties).



View larger version (15K):
[in this window]
[in a new window]
 
Fig 4. The effect of a 25% reduction in end-diastolic diameter (Myosplint) on the transmural distribution of (B) end-diastolic and (C) end-systolic fiber stress. Note the significant reduction in fiber stress in areas "far" from the Myoslint. (A) Areas that are "near" and "far" from the Myosplints are indicated. (kPa = Pascal x103; * = comparison between preoperative and "near;" {dagger} = comparison between preoperative and "far;" p less than 0.05 by two-way ANOVA with Bonferroni correction.)

 
Statistical analysis
Finite element simulations produce discrete results. However, the group of nine models was assumed to represent biologic variability and grouped together and analyzed using standard statistical techniques. The effect of diastolic and systolic material properties on the change in the Starling relationship that occurred with Myosplint was determined with a multiple linear regression where dummy variables were used to determine the effect of material variables (C and Ca0) and arterial elastance (EA) on the ß0,Starling and ß1,StarlingPED terms [25, 27]. The effect of diastolic and systolic material properties on the reduction in stress that occurred with Myosplint was determined with a two-way ANOVA with Bonferroni correction [25]. All values are expressed as mean ± standard deviation. Significance of regression analysis and ANOVA (Systat, version 9, SPSS Inc., Chicago IL) was set at p less than 0.05.


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
End-diastolic and end-systolic finite element meshes after a 25% end-diastolic diameter reduction are illustrated in Figures 5A and 5B, respectively. In each panel the ventricular wall is represented by a "wire-frame" and the inner surfaces of each element have been "rendered." The diastolic model is loaded with 20 mm Hg of intracavitary LV pressure, and the systolic model is loaded with 100 mm Hg. Note that each Myosplint is anchored at a single epicardial point, and indentation of the epicardial surface at the point of simulated Myosplint attachment is greater than that of the endocardium.



View larger version (43K):
[in this window]
[in a new window]
 
Fig 5. (A) Diastolic and (B) end-systolic finite element meshes after a 25% reduction in end-diastolic diameter at the points of application of three Myosplints. The diastolic model has "failing" material properties (see text) and is loaded with 20 mm Hg of intracavitary left ventricular pressure. The end-systolic model also has failing material properties and is loaded with 100 mm Hg of intracavitary left ventricular pressure. The red rendered surface is the endocardium; blue lines outline the finite elements; arrows indicate the points of Myosplint attachment.

 
Preoperative diastolic and end-systolic pressure-volume relationships are seen in Figures 6A–6C. Figure 6A illustrates the three diastolic compliance curves associated with C of 0.88, 1.10, and 1.40 kPa, respectively (Eqn. 1 and Table 1). Figure 6B reveals the three end-systolic elastance curves associated with Ca0 of 2.66, 2.30, and 2.00 µmol/L, respectively, and C = 0.88 kPa. Figure 6C is similar to Figure 6B but with C = 1.4 kPa. Note that the position of each end-systolic elastance curve is dependent on both the diastolic stiffness and peak intracellular calcium concentration (position relative to dashed reference line at 350 mL).



View larger version (17K):
[in this window]
[in a new window]
 
Fig 6. Baseline (preoperative) diastolic (A) and end-systolic (B and C) pressure-volume relationships. (A) Diastolic compliance associated with C of 0.88, 1.10, and 1.40 kPa, respectively (Equation 1 and Table 1). (B) End-systolic elastance curves associated with Ca0 = 2.66, 2.30, and 2.00 µmol/L, respectively, and C = 0.88 kPa. (C) Similar to B but with C = 1.4 kPa. Note that the elastance is dependent on both the diastolic stiffness variable and peak intracellular calcium concentration. (LV = left ventricle.)

 
The effect of a 25% reduction in end-diastolic diameter (Myosplint) on end-systolic elastance and diastolic compliance is demonstrated in Figure 2A. Myosplint application increased the slope (aggregate data) of the end-systolic elastance from 0.62 to 0.75 mm Hg/mL (p = 0.00058) and increased the linear term of the diastolic compliance from 0.027 to 0.031 mm Hg/mL (p = 0.00000). Both C and Ca0 had a significant positive effect on the slope of end-systolic elastance (C = 0.011, p = 0.00000; Ca0 = 0.015, p = 0.00000). Nonlinearity of end-systolic elastance before and after Myosplint is illustrated in Figure 2B. Note that the preoperative end-systolic elastance curves to the right and after simulated Myosplint bends slightly to the left (p = 0.00070). Although not presented, the effects of individual Myosplint simulations on diastolic and end-systolic LV stiffness variables are available upon request.

Average end-systolic volume was reduced from 299.7 to 273.9 mL at 100 mm Hg (8.6%) and average end-diastolic volume was reduced from 382.1 to 353.0 mL at 20 mm Hg (7.6%). Average ejection fraction did not change (preoperative 21.47% versus Myosplint 21.48%).

The overall effect of Myosplint on the Starling relationship was not significant. However, Figure 3 documents an effect of arterial elastance. For instance, Figure 3A illustrates the effect when preoperative EA is calculated by fixing LV pressure at 100 mm Hg. Figure 3B demonstrates the effect when preoperative EA is fixed at 2, 2.5, or 3. In all cases preoperative EA = Myosplint EA. There was a trend toward an improvement in the Starling relationship at low diastolic stiffness (C) (ß1,Starling term = -0.156, p = 0.29), high peak intracellular calcium concentration (Ca0) (ß1,Starling term = 0.048, p = 0.595), and high arterial elastance (EA) (ß1,Starling term = 0.049, p = 0.510).



View larger version (14K):
[in this window]
[in a new window]
 
Fig 3. The effect of a 25% reduction in end-diastolic diameter (Myosplint) on the stroke volume/end-diastolic pressure (Starling) relationship. (A) Preoperative EA is calculated by fixing LV pressure at 100 mm Hg. (B) Preoperative EA is fixed at 2, 2.5, or 3. In all cases preoperative EA = Myosplint EA. Although changes were not significantly different (all cases) there is a trend toward an improvement in the Starling relationship at high EA. Note the change in scale in panel B. (ED = end-diastolic; LV = left ventricle.)

 
The effect of a 25% reduction in end-diastolic diameter (Myosplint) on the transmural distribution of end-diastolic and end-systolic fiber stress is illustrated in Figure 4. Although these distributions are axisymmetric in the presplinted case, those at locations of the model near and far from the 25% end-diastolic diameter reduction are quite different. Note that Myosplints decrease fiber stress throughout the cardiac cycle at all transmural locations (especially in the subendocardium) that are far from their points of application. Near these points, however, Myosplints actually increase fiber stress (slightly) at some transmural (midwall) locations.

The effect of Myosplint on mean fiber stress throughout the LV wall for all combinations of diastolic and systolic material properties is indicated in Table 2. End-diastolic and end-systolic stresses were obtained at 20 and 100 mm Hg, respectively. Note that mean fiber stress decreases with the 25% end-diastolic diameter reduction by 23.0% to 23.7% at end-diastole and by 13.0% to 15.8% at end-systole.


View this table:
[in this window]
[in a new window]
 
Table 2. Effect of Myosplints on End-Diastolic and End-Systolic Mean Fiber Stresses

 

    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
In summary, we developed a realistic mathematical model of a globally dilated LV and used it to study the effects of Myosplint on ventricular function and mechanics for a wide range of diastolic and systolic material properties. The primary finding is that end-diastolic and end-systolic mean fiber stress were decreased by 24% and 16%, respectively. Although the effect of Myosplint on the Starling relationship was not significant, there were trends toward an improvement in this relationship at low diastolic stiffness, C, high peak intracellular calcium concentration, Ca0, and high arterial elastance, EA. Of note, the effect of C was twice that of Ca0 and EA. Diastolic function would be expected to be the prime determinant of success with Myosplint.

In a closed circular chamber, if two opposing walls are brought together, thereby reducing the radius of curvature of the adjacent walls, and, presumably, the wall stress in those walls, one might ask why does the region of the chamber where the walls are flattened out by Myosplint not have an offsetting increase in wall stress? Qualitative static analysis indicates that the internal pressure in the ventricle has to be in perfect balance with the stresses in the wall of the ventricle and the tensile forces acting on Myosplint. In other words, Myosplint and wall of the heart act structurally in parallel to contain internal ventricular pressure. Therefore, the overall mean stresses in the ventricle are reduced with the application of Myosplint. Regional stress distributions are more difficult to qualitatively ascertain. In the vicinity of the Myosplint, big changes in radius of curvature take place and a subsequent rise in stresses is observed in those areas. But this happens only locally and the overall mean stresses are reduced as evidenced in the "far" and "near" stress figures.

The change in the curvature of the end-systolic pressure-volume relationships illustrated in Figures 3A and 3B is due to the rigid Myosplint. Specifically, at small LV end-systolic volumes, Myosplint would be expected to have little effect. However, as one moves to the right on the end-systolic pressure-volume curve the length of Myosplint relative to the diameter of the unconstrained chamber becomes proportionally smaller. This forces the end-systolic pressure-volume curve to deviate progressively to the left. Myosplint has a similar effect on diastolic compliance, but because compliance is normally nonlinear, the effect is masked.

Comparison with animal experiments
When compared with application of the Myosplint device in dogs with pacing tachycardia-induced heart failure [11], our simulations underestimate the effect of Myosplint application on both ventricular volume and fiber stress. For instance, simulations predicted that LV end-diastolic and end-systolic volumes were reduced by 7.6% and 8.6%, respectively, whereas application in dogs with heart failure [11] caused an acute reduction in end-diastolic and end-systolic volume of 38 and 51%, respectively. The reason is graphically illustrated in Figure 5. Specifically, because each Myosplint is attached to a single point on the myocardium, indentation of the epicardial surface at the point of simulated attachment is greater than that of the endocardium. The addition of an anchoring pad to the simulation would have probably produced a greater "volume" effect at the endocardium. However, we estimate (with current computer hardware [Octane 2]) refinement of the finite element mesh necessary to simulate the anchoring pads would cause simulations to run for 3 weeks before convergence. Revised simulations are not practical until software is adapted to allow the use of multiple parallel processors.

Comparison with partial ventriculectomy
In previous finite element model studies [15, 19] our simulations suggested that there is something fundamentally wrong with partial ventriculectomy from a global cardiac mechanics point of view because its net effect was a depression of ventricular function (as measured by the Starling relationship) regardless of the choice of myocardial material properties and baseline ventricular geometry. Comparison of Figure 4 in that previous study [19] with Figure 3 in the present study clearly demonstrates that partial ventriculectomy depresses ventricular function a great deal more than Myosplints do. Both surgical therapies successfully reduced regional wall stress in our model. Comparison of Table III in that previous study [19] with Table 2 in the present study reveals that a 25% end-diastolic diameter reduction decreases end-diastolic mean fiber stresses by an amount (23.0% to 23.7% depending on material properties) comparable to that of a 20% ventricular volume reduction (22.5% to 24.1% depending on whether or not residual stress is taken into account). Similarly, a 25% end-diastolic diameter reduction decreases end-systolic mean fiber stresses by an amount (13.0% to 15.8%) comparable to that of a 10% ventricular volume reduction (12.0% to 12.3%).

Fiber stress
Direct measurement of ventricular wall stress in the intact heart is impossible because of tethering from surrounding myocardium [28]. An alternative approach to quantifying ventricular wall stress is mathematical modeling based on the conservation laws of continuum mechanics. To solve the governing equations of equilibrium for a pressure vessel with such a complex geometry, boundary conditions, and material properties, computational techniques are required. The most versatile technique for analyzing cardiac mechanics is the finite element method [29].

Many finite element models of the left ventricle have been proposed. However, most have assumed that the myocardium is linearly elastic (Hooke’s law) [5, 30]. Of note, finite element analysis with a linearly elastic material is computationally efficient because iterative solutions are not required. However, description of myocardium with a nonlinear constitutive relationship is not only more realistic but may allow significantly more accurate calculations [31]. For instance, Janz and Grimm [32] found that a linear elastic model was able to predict pressure-volume relationships but unable to predict fiber elongation.

Furthermore, most large deformation nonlinear [32] and most linear [5, 30] finite element models of the left ventricle have treated the myocardium as an isotropic material. We have previously modeled the effect of the ventricular muscle-fiber distribution with finite elements that possess material anisotropy with respect to a continuously varying fiber axis [24]. In addition, the incompressibility of the heart muscle, which is composed mostly (80%) of water, has very often been incorrectly accounted for by assuming that the myocardium has a Poisson ratio close to 0.5 [5, 30]. Our previous study more correctly introduced the hydrostatic pressure as a Lagrange multiplier in the strain energy function [24]. Solutions indicated that the stiffness of passive myocardium would be 2.4 to 6.6 times greater in the fiber direction, which agrees with the results of biaxial tissue testing. Of note, this study and our previous analysis of partial ventriculectomy [19], represent the first analyses of a surgical remodeling procedure on fiber stress using a nonlinear stress-strain relationship for the diastolic myocardium that is anisotropic with respect to the local muscle fiber direction.

Effect of arterial elastance
In our prior simulations of partial ventriculectomy [19] and cellular transplantation [33], EA was held constant during the calculation of each stroke volume/PED curve. However, because the calculation of each curve began at PES of 100 mm Hg and PED of 20 mm Hg, by necessity each simulation had a different value of EA. This may have significantly biased our previous calculations [19] because EA typically rose after simulated partial ventriculectomy, and higher afterload (EA) would be expected to depress the Starling relationship. In the future, we plan to investigate this in more detail. However, in this study all Starling curves, including preoperative and Myosplint simulations, were calculated with a constant EA (2.0, 2.5, and 3.0 mm Hg/ml). This is a significant departure from our previous report [19] in which we used the relationship between stroke volume and EA described by Sagawa [34] to calculate the stroke volume/PED relationship.

Conclusion and future directions
The present model study is a significant improvement over previous attempts to predict the effect of Myosplint on ventricular function and mechanics [11]. The thickness of Myosplint is very small in comparison to other dimensions in the problem (i.e., thickness of the heart). Producing a meshing scheme that produces elements at least as small as Myosplint thickness (e.g., with four instead of one constrained node) will necessitate an increase in the degrees of freedom of the problem beyond our present computational capabilities. Because the main focus of the study is on mean fiber stresses and pressure-volume relationships that are not affected by the exact distribution of stresses right at the Myosplint interfaces (by virtue of Saint Venant’s principle) [35], we believe our Myosplint modeling simplification is acceptable. Again, increasing the number of elements from 180 to 384 changed the LV volume results by less than 2%. However, in the future, the effect of different Myosplint number, configurations, and tension needs to be performed. In addition, model predictions need to be confirmed by comparison with three-dimensional myocardial deformation and strain, measured using magnetic resonance imaging with noninvasive tags. Nevertheless, current results suggest that "shape change" therapy is a mechanically viable therapy for heart failure.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
This study was supported by National Institutes of Health grants R01-HL-58759 (Dr Guccione) and R01-HL-63348 (Dr Ratcliffe); and by Myocor, Inc, Maple Grove, MN.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Weber K.T., Janicki J.S. Myocardial oxygen consumption: the role of wall force and shortening. Am J Physiol 1977;233:H421-430.
  2. Bavaria J.E., Furukawa S., Kreiner G., et al. Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg 1990;100:210-220.[Abstract]
  3. Laskey W.K., Reichek N., St John Sutton M., Untereker W.J., Hirshfeld J.W., Jr Matching of myocardial oxygen consumption to mechanical load in human left ventricular hypertrophy and dysfunction. J Am Coll Cardiol 1984;3:291-300.[Abstract]
  4. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
  5. Aikawa Y., Rohde L., Plehn J., et al. Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the healing and early afterload reducing trial (HEART): an echocardiography-based structural analysis. Am Heart J 2001;141:234-242.[Medline]
  6. Pimentel D.R., Amin J.K., Xiao L., et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001;89:453-460.[Abstract/Free Full Text]
  7. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res 1998;82:482-495.[Abstract/Free Full Text]
  8. Gomez A.M., Valdivia H.H., Cheng H., et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276:800-806.[Abstract/Free Full Text]
  9. Heerdt P.M., Holmes J.W., Cai B., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 2000;102:2713-2719.[Abstract/Free Full Text]
  10. Li Y.Y., Feng Y., McTiernan C.F., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 2001;104:1147-1152.[Abstract/Free Full Text]
  11. McCarthy P.M., Takagaki M., Ochiai Y., et al. Device-based change in left ventricular shape. a new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg 2001;122:482-490.[Abstract/Free Full Text]
  12. Batista R.J., Santos J.L., Takeshita N., Bocchino L., Lima P.N., Cunha M.A. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996;11:96-98.[Medline]
  13. McCarthy J.F., McCarthy P.M., Starling R.C., et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg 1998;13:337-343.
  14. Dickstein M.L., Spotnitz H.M., Rose E.A., Burkhoff D. Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg 1997;113:1032-1040.[Abstract/Free Full Text]
  15. Ratcliffe M.B., Hong J., Salahieh A., Ruch S., Wallace A.W. The effect of ventricular volume reduction surgery in the dilated, poorly contractile left ventricle: a simple finite element analysis. J Thorac Cardiovasc Surg 1998;116:566-577.[Abstract/Free Full Text]
  16. Missov E., Bianco R., Berry J., et al. Device based left ventricular shape change acutely reduces left ventricular volumes and improves ejection franction in an ovine model of ischemic left ventricular failure. J Card Failure 2002;8:S36.
  17. Costa K.D., Hunter P.J., Wayne J.S., Waldman L.K., Guccione J.M., McCulloch A.D. A three-dimensional finite element method for large elastic deformations of ventricular myocardium: II–Prolate spheroidal coordinates. J Biomech Eng 1996;118:464-472.[Medline]
  18. Guccione J.M., Costa K.D., McCulloch A.D. Finite element stress analysis of left ventricular mechanics in the beating dog heart. J Biomech 1995;28:1167-1177.[Medline]
  19. Guccione J.M., Moonly S.M., Wallace A.W., Ratcliffe M.B. Residual stress produced by ventricular volume reduction surgery has little effect on ventricular function and mechanics: a finite element model study. J Thorac Cardiovasc Surg 2001;122:592-599.[Abstract/Free Full Text]
  20. Fujita M., Hartiala J., O’Sullivan M., et al. Assessment of left ventricular diastolic function in dilated cardiomyopathy with cine magnetic resonance imaging: effect of an angiotensin converting enzyme inhibitor, benazepril. Am Heart J 1993;125:171-178.[Medline]
  21. Streeter D.D., Jr, Spotnitz H.M., Patel D.P., Ross J., Jr, Sonnenblick E.H. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 1969;24:339-347.[Abstract/Free Full Text]
  22. Kresh J.Y., Wechsler A.S. Heart reduction surgery can reconstitute the residual stress-strain state of the left ventricle. J Thorac Cardiovasc Surg 1998;116:1084-1086.[Free Full Text]
  23. Rodriguez E.K., Omens J.H., Waldman L.K., McCulloch A.D. Effect of residual stress on transmural sarcomere length distributions in rat left ventricle. Am J Physiol 1993;264:H1048-1056.
  24. Guccione J.M., McCulloch A.D., Waldman L.K. Passive material properties of intact ventricular myocardium determined from a cylindrical model. J Biomech Eng 1991;113:42-55.[Medline]
  25. Kleinbaum D., Kupper L., Muller K. Applied regression analysis and other multivariable methods. Boston: PWS-Kent, 1988.
  26. Feldman M.D., Pak P.H., Wu C.C., et al. Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Time- and dose-dependence analysis based on pressure-volume relations. Circulation 1996;93:474-483.[Abstract/Free Full Text]
  27. Glantz S., Slinker B. Primer of applied regression and analysis of variance. Columbus, OH: McGraw-Hill, 2000.
  28. Huisman R.M., Elzinga G., Westerhof N., Sipkema P. Measurement of left ventricular wall stress. Cardiovasc Res 1980;14:142-153.[Medline]
  29. McCulloch A., Waldman L., Rogers J., Guccione J. Large-scale finite element analysis of the beating heart. Crit Rev Biomed Eng 1992;20:427-449.[Medline]
  30. Moustakidis P., Maniar H.S., Cupps B.P., et al. Altered left ventricular geometry changes the border zone temporal distribution of stress in an experimental model of left ventricular aneurysm: a finite element model study. Circulation 2002;106:I168-175.
  31. Yin F.C.P. Ventricular wall stress. Circ Res 1986;49:829-842.
  32. Janz R.F., Grimm A.F. Deformation of the diastolic left ventricle. Nonlinear elastic effects. Biophys J 1973;13:689-704.
  33. Quarterman R.L., Moonly S., Wallace A.W., Guccione J., Ratcliffe M.B. A finite element model of left ventricular cellular transplantation in dilated cardiomyopathy. Asaio J 2002;48:508-513.[Medline]
  34. Sagawa K. Cardiac contraction and the pressure-volume relationship. New York: Oxford University Press, 1988.
  35. Fung Y.C. Foundations of solid mechanics. Upper Saddle River, NJ: Prentice Hall, 1965.



This article has been cited by other articles:


Home page
HeartHome page
E. B Friedrich and M. Bohm
MANAGEMENT OF END STAGE HEART FAILURE
Heart, May 1, 2007; 93(5): 626 - 631.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Nohria and M. M. Givertz
B-Type Natriuretic Peptide and the Stressed Heart
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 749 - 751.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. B. C. Dang, J. M. Guccione, J. M. Mishell, P. Zhang, A. W. Wallace, R. C. Gorman, J. H. Gorman III, and M. B. Ratcliffe
Akinetic myocardial infarcts must contain contracting myocytes: finite-element model study
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1844 - H1850.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. B.C. Dang, J. M. Guccione, P. Zhang, A. W. Wallace, R. C. Gorman, J. H. Gorman III, and M. B. Ratcliffe
Effect of Ventricular Size and Patch Stiffness in Surgical Anterior Ventricular Restoration: A Finite Element Model Study
Ann. Thorac. Surg., January 1, 2005; 79(1): 185 - 193.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mark B. Ratcliffe
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guccione, J. M.
Right arrow Articles by Ratcliffe, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guccione, J. M.
Right arrow Articles by Ratcliffe, M. B.
Related Collections
Right arrow Mechanical Circulatory Assistance


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS